Journals / Experimental Biomedical Research / 2021 / Cilt: 4 - Sayı: 1

Evaluation of risk factors associated with pancreatic adenocarcinoma in Black Sea region, Turkey

Pages
38–46
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Determination of pancreatic cancer risk factors, organization of imaging and screening programs for high-risk people can provide early diagnosis of the disease and prolong survival.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To evaluate the risk factors in patients with pancreatic adenocarcinoma in Turkey's Black Sea region and to determine groups at high risk for pancreatic cancer.
📊
Key Findings & Data:Methods: 106 newly diagnosed pancreatic adenocarcinoma patients living in Black Sea region of Turkey who applied to our clinic between January 2015 and December 2016 were included in this study.
💡
Conclusion & Impact:Conclusion: Determination of pancreatic cancer risk factors, organization of imaging and screening programs for high-risk people can provide early diagnosis of the disease and prolong survival.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

Aim: To evaluate the risk factors in patients with pancreatic adenocarcinoma in Turkey's Black Sea region and to determine groups at high risk for pancreatic cancer. Methods: 106 newly diagnosed pancreatic adenocarcinoma patients living in Black Sea region of Turkey who applied to our clinic between January 2015 and December 2016 were included in this study. In the same period a control group was formed with 92 patients of similar age. Both groups were asked to fill out a form that questioned the pancreatic cancer risk factors. Data were analyzed. Results: Pancreatic cancer risk was 3.5 times higher in people over 65 years of age. Patients with deficient level of serum vitamin D level (<20 ng/ml) had 10.2 times more risk of pancreatic cancer than patients with normal level of Vitamin D (≥30 ng/ml). While newly diagnosed type 2 diabetics had 19.5 times higher risk of pancreatic cancer, long term type 2 diabetics had 1.2 times higher risk than normal individuals. Those with pancreatic cancer in family had 4.3 times higher risk than those who did not. It was observed that people with rhesus (Rh) antigen negative blood group has 70% less risk of pancreatic cancer. Conclusion: Determination of pancreatic cancer risk factors, organization of imaging and screening programs for high-risk people can provide early diagnosis of the disease and prolong survival.

🔖

Cite This Article

DEREBEY, M., KARABULUT, K., YURUKER, S. S., KARABICAK, İ., ÖZEN, N. (2021). Evaluation of risk factors associated with pancreatic adenocarcinoma in Black Sea region, Turkey. Experimental Biomedical Research, Cilt: 4 - Sayı: 1, 38–46. https://ajindex.com/articles/201528

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Huxley R, Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005;92(11):2076-83. [2]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. [3]Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-100. [4]Kimura Y, Hirata K, Mukaiya M, et al. Hand-assisted laparoscopic pyloruspreserving pancreaticoduodenectomy for pancreas head disease. Am J Surg. 2005;189(6):734-37. [5]Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22(44):9694-5. [6]Lippi G, Mattiuzz C. The global burden of pancreatic cancer. Arch Med Sci. 2020;16(4):820-24. [7]Hidalgo M, Cascinu S, Kleeff J, et al. Addressing the challanges of pancreatic cancer: future directions for improving outcomes. Pancreatology. 2015;15(1):8-18. [8]Ferlay J, Soerjomataram I, Ervik M, et al. Cancer incidence and mortality worldwide. International Agency for Research on Cancer, 2013; http://globocan.iarc.fr 5. [9]American Cancer Society. Cancer facts and figures 2013.
  2. Atlanta, Ga: American Cancer Society, 2013. [10]Stolzenberg-Solomon RZ, Jacobs EJ, et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):81-93. [11]Kasiappan R, Sun Y, Lungchukiet P, et al. Vitamin D suppresses leptin stimulation of cancer growth through microRNA. Cancer Res. 2014;74(21):6194-204. [12]Iodice S, Gandini S, Maisonneuve P, et al. Langenbecks Arch Surg. 2008;393(4):535- 45. [13]Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625-38. [14]Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008;134(4):981-87. [15]Benzel J, Fendrich V. Familial Pancreatic Cancer. Oncol Res Treat. 2018;41(10):611- 18. [16]Michaud DS, Vrieling A, Jiao L, et al. Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control. 2010;21(8):1213-5. [17]Farrow DC, Davis S. Risk of pancreatic cancer in relation to medical history and the use tobacco, alcohol and coffee. Int J Cancer. 1990;45(5):816-20. [18]Kudo Y, Kamisawa T, Anjiki H, et al. Incidence of and risk factors for developing pancreatic can